Company Filing History:
4 out of 601 
3 out of 10 
1 out of 1 Years Active: 1990-1996
Title: Innovations of Patrick Kanda in Atherosclerosis Treatment
Introduction
Patrick Kanda is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of biomedical research, particularly in the area of atherosclerosis treatment. With a total of seven patents to his name, Kanda's work focuses on innovative polypeptide antibodies that target cholesteryl ester transfer protein (CETP).
Latest Patents
Kanda's latest patents include a CETP inhibitor polypeptide that demonstrates the ability to inhibit cholesteryl ester transfer protein. This invention is crucial in developing anti-atherosclerosis compositions that contain an effective amount of the polypeptide along with a pharmaceutically acceptable carrier. Additionally, he has developed an anti-atherosclerosis kit that includes the composition, a syringe, and a needle in separate sterile containers. His patents also describe methods for preventing and treating atherosclerosis in mammals by administering therapeutically effective amounts of the polypeptide.
Career Highlights
Throughout his career, Patrick Kanda has worked with esteemed institutions such as Baylor College of Medicine and the Southwest Foundation for Biomedical Research. His research has significantly advanced the understanding and treatment of atherosclerosis, showcasing his dedication to improving health outcomes.
Collaborations
Kanda has collaborated with notable colleagues, including James T. Sparrow and Ronald C. Kennedy. These partnerships have further enriched his research and contributed to the development of innovative solutions in the biomedical field.
Conclusion
Patrick Kanda's contributions to the field of atherosclerosis treatment through his innovative patents and collaborations highlight his role as a leading inventor in biomedical research. His work continues to pave the way for advancements in medical treatments.